Seeking Alpha

Medical device manufacturer Haemonetics (HAE -3.5%) gets hit after its FQ2 misses EPS estimates,...

Medical device manufacturer Haemonetics (HAE -3.5%) gets hit after its FQ2 misses EPS estimates, despite beating on revenue. Profits rose 8% Y/Y, but net income declined 35% due to quality issues with its HS Core Bowl and the recall of its OrthoPAT device.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs